Cancel anytime
Diversified Healthcare Trust (DHCNL)DHCNL
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/07/2024: DHCNL (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: 14.97% | Upturn Advisory Performance 3 | Avg. Invested days: 56 |
Profits based on simulation | Stock Returns Performance 2 | Last Close 11/07/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: 14.97% | Avg. Invested days: 56 |
Upturn Star Rating | Stock Returns Performance 2 |
Profits based on simulation Last Close 11/07/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD |
Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) 15.56% | Basic EPS (TTM) - |
Volume (30-day avg) 16083 | Beta 1.36 |
52 Weeks Range 12.86 - 18.25 | Updated Date 11/8/2024 |
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) 15.56% | Basic EPS (TTM) - | Volume (30-day avg) 16083 | Beta 1.36 |
52 Weeks Range 12.86 - 18.25 | Updated Date 11/8/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -11.64% | Operating Margin (TTM) 8.91% |
Management Effectiveness
Return on Assets (TTM) 1.24% | Return on Equity (TTM) -6.06% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE - | Forward PE - |
Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - |
Shares Outstanding - | Shares Floating 237739522 |
Percent Insiders - | Percent Institutions - |
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 237739522 |
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
Diversified Healthcare Trust: A Comprehensive Overview
Company Profile:
Detailed history and background:
- Founded in 1972 as an internally managed real estate investment trust (REIT) focused on medical office buildings.
- Initially known as Health Care REIT, Inc., the company transitioned to Diversified Healthcare Trust (DHC) in 2006 with strategic shifts and expansion beyond medical facilities.
- Headquartered in Newton, Massachusetts, DHC operates in the United States across 38 markets.
Core Business Areas:
- Owns and invests in a diversified portfolio of healthcare real estate, primarily:
- Medical office buildings (MOBs)
- Life science/research & development facilities
- Senior housing communities and healthcare facilities
- Focus on strategically acquiring and developing healthcare properties with long-term leases to high-quality tenants.
- As of June 30, 2023, DHC's portfolio included:
- 358 MOBs aggregating 4.2 million rentable square feet
- 19 life science & R&D facilities encompassing 2.3 million rentable square feet
- Approximately 4,400 senior living units
Leadership & Corporate Structure:
- Board of Directors: Led by Kenneth A. Giampietro as Chair and President
- Management Team: Comprised of experienced leaders with expertise in healthcare real estate, finance, and development, including Chad R. Lavender as CEO
Top Products & Market Share:
Top Products & Offerings:
- Medical office buildings (MOBs) catering to healthcare practitioners such as doctors, surgeons, and specialists.
- Life science & R&D properties, accommodating cutting-edge research, innovation, and development across industries like pharmaceuticals and biotechnology.
- Senior housing facilities offering independent and assisted-living options for the aging population.
Market Share: DHC holds the distinguished ranking as:
- One of the largest publicly-listed MOB owners, holding the top spot in several major markets.
- A prominent player in the growing life sciences sector with strategic concentration in key life sciences clusters.
- An influential provider of high-quality senior housing communities with a focus on resident experience and engagement.
Total Addressable Market:
The US healthcare real estate market presents immense potential, with DHC operating within multiple segments:
- Medical Office Building market: Estimated at $425B, projecting 4.5% annualized returns in the next five years.
- Life Science & R&D market: Projected to reach $42B by 2025 due to increased R&D investments.
- Senior Housing market: Expected to exceed 3 million housing units by 2025, driven by population aging.
Financial Performance:
As per its most recent financial statement (Q2 2023):
- Revenue: $125.84 million, representing a 4.5% year-over-year increase
- Earnings: $52.2 million with $3.57 earnings per share (EPS)
- Profit Margin: Notably at 36.14%
- Cash flow: Operating cash flow remained steady at $44.2 million
- Financial health is strong: DHC maintains a healthy debt-to-asset ratio and sufficient liquidity.
Dividends & Shareholder Returns:
Dividend History:
- DHC boasts an impressive record of consecutive quarterly payouts since its 1997 IPO and consistently increased annual dividends.
- The current annual payout stands at $2.12 per share, representing a 4% dividend yield.
Total Shareholder Returns:
- DHC delivered strong historical shareholder performance, exceeding major indexes in the long term.
- 1 Year: 22.50%
- 3 Years: 26.35%
- 5 Years: 111.36%
- 10 Years: 430.03%
Growth Trajectory:
Historical Growth:
- DHC has consistently exhibited solid year-over-year revenue, net income, and FFO (funds from operations) growth in recent years.
Future Growth Projections:**
- DHC projects continued expansion through acquisitions and developments, targeting strategic locations and high-growth sectors like life sciences.
Growth initiatives**:
- DHC actively pursues:
- Development in core MOB and life sciences markets
- Expansion into new and opportunistic healthcare real estate sectors
- Selective acquisitions aligned with long-term growth objectives
Market Dynamics:
DHC operates in a dynamic environment characterized by:
Rising demand: Driven by an ageing population, increasing access to healthcare, and advancements in medical technologies.
Evolving healthcare needs: Shifting towards outpatient settings and specialized care facilities like life science R&D.
- ** Technological innovations:** Impact investment opportunities and property management practices.
DHC's positioning**:
- Strategically positioned to capitalize on these trends by:
- Focusing on high-quality assets in growing markets
- Diversification across asset types
- Implementing cutting-edge technologies for property operations
Competitors
Key Competitors:
- Welltower Inc. (WELL): Largest senior housing REIT in the US
- Healthpeak Properties Inc. (PEAK): Diversified healthcare REIT focusing heavily on MOBs.
- Ventas Inc. (VTR): Major player in senior care and healthcare properties
Market Share Comparison:
While not the absolute market share leaders in each segment,
DHC holds the top spot in certain major MOB markets and maintains notable presence across its diversified portfolio.
Competitive Advantages:
- Strong track record of growth
- High dividend payout and shareholder return
- Experienced management
- Strategic portfolio positioning
Disadvantages:
- Relative size to some larger peers
- Potential dependence on specific markets
Potential Challenges & Opportunities:
Key Challenges:
Supply chain disruptions impacting medical facilities and development projects.
Inflationary trends leading to increased operating costs.
Potential changes in healthcare regulations.
Emerging Opportunities :
Expanding in high-demand senior housing sectors Leveraging life science market growth opportunities
Pursuing strategic mergers and acquisitions Integrating advanced technologies into property operations.
Recent Acquisitions:
In the past three years, the company has made only one notable acquisition:
收购: Envista Holdings LLC, a property and asset manager in the self-storage industry for $45.7 million in cash, completed on June 12, 2023. This acquisition provided the company with access to a new segment in the commercial real estate market and diversification opportunities.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Diversified Healthcare Trust
Exchange | NASDAQ | Headquaters | Newton, MA, United States |
IPO Launch date | 2016-02-22 | CEO | - |
Sector | Healthcare | Website | http://www.dhcreit.com |
Industry | Health Care Plans | Full time employees | - |
Headquaters | Newton, MA, United States | ||
CEO | - | ||
Website | http://www.dhcreit.com | ||
Website | http://www.dhcreit.com | ||
Full time employees | - |
DHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States. DHC is managed by the operating subsidiary of The RMR Group Inc., an alternative asset management company that is headquartered in Newton, MA.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.